| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CVR/CVP303 |
| P698 | PubMed publication ID | 19726439 |
| P50 | author | John Pernow | Q55414577 |
| Adrian T Gonon | Q59681999 | ||
| P2093 | author name string | Christian Jung | |
| Jon O Lundberg | |||
| Per-Ove Sjöquist | |||
| P433 | issue | 1 | |
| P304 | page(s) | 147-154 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Arginase inhibition mediates cardioprotection during ischaemia-reperfusion | |
| P478 | volume | 85 |
| Q90026495 | A Novel Histidine-Tryptophan-Ketoglutarate Formulation Ameliorates Intestinal Injury in a Cold Storage and ex vivo Warm Oxygenated Reperfusion Model in Rats |
| Q35217395 | Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function |
| Q37603245 | Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury |
| Q58127032 | Arginase II Contributes to the Ca/CaMKII/eNOS Axis by Regulating Ca Concentration Between the Cytosol and Mitochondria in a p32-Dependent Manner |
| Q39012928 | Arginase Inhibitors: A Rational Approach Over One Century |
| Q37676877 | Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome |
| Q38082329 | Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? |
| Q34800913 | Arginase in retinopathy |
| Q28081566 | Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart |
| Q34730537 | Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice |
| Q35181215 | Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia. |
| Q42575631 | Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model |
| Q37173246 | Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity |
| Q50996032 | Arginase-2 mediates renal ischemia-reperfusion injury. |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q38452432 | Arginase: an old enzyme with new tricks |
| Q36454194 | Arginine de novo and nitric oxide production in disease states |
| Q44569205 | Comparative pharmacokinetics of N(ω)-hydroxy-nor-L-arginine, an arginase inhibitor, after single-dose intravenous, intraperitoneal and intratracheal administration to brown Norway rats. |
| Q35910804 | Cross-talk Between Nitrate-Nitrite-NO and NO Synthase Pathways in Control of Vascular NO Homeostasis |
| Q35215102 | Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus |
| Q34501755 | Enteral arginase II provides ornithine for citrulline synthesis |
| Q43091435 | FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1. |
| Q91741207 | HuangqiGuizhiWuwu Decoction Prevents Vascular Dysfunction in Diabetes via Inhibition of Endothelial Arginase 1 |
| Q35078422 | Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational diabetic mothers |
| Q47229467 | Increased levels of circulating arginase I in overweight compared to normal weight adolescents. |
| Q48835562 | Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes. |
| Q35552149 | Inorganic nitrite therapy: historical perspective and future directions. |
| Q34444733 | Late onset oral treatment with tranilast following large myocardial infarction has no beneficial effects on cardiac remodeling and mortality in rats |
| Q34364451 | Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production |
| Q33738817 | Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1. |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q33594387 | Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress |
| Q34934327 | Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q90152264 | Norvaline Reduces Blood Pressure and Induces Diuresis in Rats with Inherited Stress-Induced Arterial Hypertension |
| Q47734746 | Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1. |
| Q38979298 | Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors |
| Q37761657 | Polyamine metabolism in Leishmania: from arginine to trypanothione |
| Q90248915 | Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arterioles |
| Q92921921 | Role of Arginase 2 in Murine Retinopathy Associated with Western Diet-Induced Obesity |
| Q34142923 | Roles of dietary inorganic nitrate in cardiovascular health and disease. |
| Q37096869 | S-nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase |
| Q36324656 | Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System |
| Q38565004 | Strategies to increase nitric oxide signalling in cardiovascular disease |
| Q40584228 | Systemic arginine depletion after a murine model of surgery or trauma |
| Q93159118 | The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia |
| Q57580303 | The effect of prolonged dietary nitrate supplementation on atherosclerosis development |
| Q21245765 | The metabolic advantage of tumor cells |
| Q34070745 | The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo |
| Q36973472 | Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction |
| Q44782961 | Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction |
| Q35632147 | Upregulation of arginase activity contributes to intracellular ROS production induced by high glucose in H9c2 cells |
| Q38941643 | Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase |
| Q89660041 | p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs |
Search more.